Myomectomies:Tumor Characteristics and Clinical Implications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02671253|
Recruitment Status : Unknown
Verified January 2016 by Päivi Päkarinen, Helsinki University Central Hospital.
Recruitment status was: Recruiting
First Posted : February 2, 2016
Last Update Posted : February 2, 2016
This project focuses on myomectomy patients in reproductive age. The aim is to study both the molecular characteristics of uterine fibroids and to characterize the clinical effects of surgical treatment.
Patient series is mainly retrospective and consists of individuals who have undergone myomectomy at Helsinki University Central Hospital (HUCH) during 2009-2015. In addition, the investigators have started a prospective sample collection starting in October 2015, collecting samples from myomectomies.
Clinical data sources include medical records, specific questionnaires and a quality of life -questionnaire filled by patients.
|Condition or disease||Intervention/treatment|
|Uterine Myomectomy Genetics Quality of Life Gynecologic Surgical Procedures||Procedure: Myomectomy|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Myomectomies:Tumor Characteristics and Clinical Implications|
|Study Start Date :||October 2015|
|Estimated Primary Completion Date :||January 2018|
- Procedure: Myomectomy
The patient series consists of consecutive patients scheduled for elective laparotomic, traditional laparoscopic or robotic assisted laparoscopic myomectomy. The surgical method is selected based on clinician´s preference.
- Quality of life measured by a validated questionnaire (UFS-QOL) [ Time Frame: Two years ]UFS-QOL: Uterine Fibroid Symptom and Health-Related Quality of Life Questionnaire
- Pregnancy rate after myomectomy, data collected with questionnaire [ Time Frame: Five years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02671253
|Contact: Päivi I Pakarinen, MD PhDemail@example.com|
|Contact: Anna K Äyräväinen, MDfirstname.lastname@example.org|
|Principal Investigator:||Päivi I Pakarinen, MD PhD||Helsinki University Central Hospital|